4.7 Meeting Abstract

Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK

Journal

ANNALS OF ONCOLOGY
Volume 32, Issue -, Pages S1069-S1069

Publisher

ELSEVIER
DOI: 10.1016/j.annonc.2021.08.1538

Keywords

-

Categories

Funding

  1. Hoffmann-La Roche Ltd.

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available